GLP-1 Cost Calculator
Pick your medication, delivery form, and how you're paying. We'll show what each provider in our vetted cohort actually costs per month, flag the trust caveats up front, and recommend the best fit.
Our pick
This is the cheapest provider in our cohort that scores 3.5 or higher on the public six-dimension rubric and has no critical trust-signal flags. Recommended for most users.
Alternative
Cheaper option exists but with material trust counterweights documented above. Choose the cheaper option only if you have read those caveats and decided you are comfortable with the operational risk.
Across our cohort
Score 2.7/5
- •BBB F rating with 25 unanswered complaints. Trustpilot suspected-fraudulent-review notice on the profile page.
- •Active Eli Lilly lawsuit (4:25-cv-03536) over compounded-tirzepatide marketing.
- •BBB complaints document a secondary $49/month subscription disclosed only in the terms of service.
Score 2.8/5
- •Affiliated compounding pharmacy Aequita received a Washington State Notice of Immediate Jeopardy in February 2026 after substantiated allegations of unlicensed-worker sterile compounding and improper cold-chain shipping.
- •Two active manufacturer lawsuits: Eli Lilly (April 2025) and Novo Nordisk 5:25-cv-06563 (August 2025; corporate-practice-of-medicine claim).
Score 4.3/5
Score 3.6/5
Score 3.6/5
- •April 2025 industry-wide FDA safety alert on compounded topical finasteride applies to Ro's product mix (different product line from GLP-1 but reflects on compounder-vendor management).
Providers in our cohort that don't serve this combination (1)
Get an email when these prices change
We re-check the cohort every month. If a provider drops a tier or raises prices, you'll hear from us. One topic, low frequency, one-click unsubscribe.
We collect your email and the topic you subscribed to, nothing else. One-click unsubscribe in every email. Topic-specific subscriptions only, never marketing.
How we built this. Monthly costs come from each provider's public pricing page (linked on each profile). Insurance estimates assume eligible commercial coverage plus the manufacturer savings card; effective cost can be as low as $0-$25/mo with the card cap. Cash-branded estimates use list price for Wegovy and Zepbound at retail without insurance.
The recommendation logic is documented in our provider vetting methodology. The 6-dimension rubric weights licensure 20%, accreditation 20%, transparency 20%, product quality 15%, pricing 15%, and customer service 10%.
What you're really paying for
GLP-1 monthly cost depends on three things, in this order: what you're taking, how it's formulated, and how you're paying. The same active ingredient can swing from $99 a month to over $1,300 depending on those three switches.
- 1.
The active ingredient.
Tirzepatide tends to run more than semaglutide, both as compounded and as branded retail. Tirzepatide is the dual GIP/GLP-1 agonist sold as Mounjaro and Zepbound; semaglutide is the GLP-1-only molecule sold as Ozempic and Wegovy.
- 2.
Compounded versus branded.
Compounded GLP-1 is mixed at a 503A or 503B pharmacy under modified-formulation rules and sold cash-pay through telehealth. Typically $99-$545/month. Branded Wegovy / Zepbound is the FDA-approved drug; without insurance it's $1,000-$1,300/month, and with eligible insurance + savings card it can land at $0-$25.
- 3.
Insurance + savings card vs cash.
If your commercial plan covers Wegovy or Zepbound, the Novo or Lilly savings card caps out-of-pocket at around $25/month for eligible patients. That's usually the cheapest path. If your plan doesn't cover it, compounded almost always beats cash-pay branded.
Why we surface trust caveats next to price
Cheap is only useful if the medication you're paying for is what the label says it is, prescribed under the rules a state pharmacy board would recognize. Several of the cheaper compounded GLP-1 options in our cohort have material flags: active manufacturer lawsuits, FDA warning letters, state-level enforcement actions, or a Better Business Bureau profile that tells a different story than the marketing.
Where the numbers come from
Each monthly range comes from the provider's public pricing page. We re-check every month and update the cost matrix when something changes. For each provider we link the source on the full profile page.
The recommendation logic uses our public 6-dimension rubric (licensure 20%, accreditation 20%, transparency 20%, product quality 15%, pricing 15%, customer service 10%). Cheapest qualified provider wins; flagged providers surface as alternatives only.